Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

Joslin Diabetes Center

Status: Completed

Conditions: Hypoglycemia; Aging; Diabetes

Study type: Observational

Funder types: Other

Identifiers

NCT05711108

STUDY00000128

Details and patient eligibility

About

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications).

This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Enrollment: 86 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults >64 years with diagnosis of type 1 or type 2 diabetes
• Using glucose-lowering medication or insulin

Exclusion criteria

• Currently taking or planning to take hydroxyurea
• Patient or Health care proxy refuses to sign consent form

Trial design

86 participants in 1 patient group

Long Term Care Residents Using Glucose Lowering Medication